Product category:
Fieldbus systems, Fibre-optic systems
News Release from: Fieldbus Foundation | Subject: Genzyme seminar
Edited by the Processingtalk Editorial
Team on 05 August 2005
Genzyme to host Foundation fieldbus
seminar
A fieldbus seminar focusing on end user applications in life sciences will be held at the Genzyme facility in Cambridge, MA, and include a tour of their Allston Landing manufacturing facility
The Fieldbus Foundation today announced that Genzyme, a leading biotech company, will host a comprehensive Foundation fieldbus seminar on November 3-4 in Cambridge, MA The event will include hands-on instruction in the use of Foundation fieldbus control systems, and feature presentations by leading worldwide experts in fieldbus technology
This article was originally published on Processingtalk on 18 Nov 2003 at 8.00am (UK)
Related stories
HSE packet analyser receives award for excellence
The Fieldbus Foundation today announced that its High Speed Ethernet (HSE) Packet Analyser Toolkit PRO (AT-442) has received an "Automation Excellence Award" from IAN Magazine
FF, HART and PNO enhances capabilities of DDL
In an unprecedented collaborative effort, three leading organisations dedicated to control network technology have completed the initial phase of development for key extensions to EDDs defined by IEC
At the Genzyme facility on Thursday, Nov 3, the Tri-State University (TSU) Technology Centre will host a workshop covering fieldbus end user applications in the pharmaceutical and biomedical industries.
The instructor will discuss implementation of the open, integrated Foundation fieldbus H1 and High Speed Ethernet (HSE) automation architecture in life sciences production environments.
The seminar will also include a tour of the Genzyme Allston Landing manufacturing facility, which includes several hundred Foundation fieldbus nodes.
Further reading
2004 General Assembly of the Fieldbus Foundation
The Fieldbus Foundation today announced that its 2004 General Assembly will be held in New Orleans, Louisiana, February 18-19, to discuss the latest fieldbus technology developments
FF Interoperability Testing Kit automation tool
The Fieldbus Foundation has released an Interoperability Testing Kit automation tool, developed for device manufacturers to accelerate the process of preparing fieldbus products for registration
FF hosts end user events at Interkama 2004
End users, integrators, contractors and engineers should book now to guarantee participation in the Fieldbus Foundation European end user council or integrator workshop, planned for Interkama 2004
Allston Landing is a licensed manufacturing site and part of the Therapeutics Business of Genzyme Corporation.
The 180,000 square foot facility has bulk manufacturing capacity for multiple products utilising recombinant mammalian cell culture.
Six 2,000 L bioreactors are used to produce recombinant enzyme products for the treatment of patients with specific lysosomal storage diseases.
These genetic disorders are ultra-orphan diseases that affect very small patient populations.
The Allston Landing site also has a product filling and lyophilisation capability for the enzymes produced there, as well as additional products manufactured at other Genzyme locations and other companies in collaboration with Genzyme.
Commercial products currently produced at Allston Landing include: Cerezyme, Fabrazyme, Thyrogen and Aldurazyme.
Catherine Cook, Genzyme director of communications, will introduce the Genzyme Corporation.
Bill Dolan PE, principle I and C engineer who has been intimately involved with the fieldbus controls at the Allston Landing facility, will deliver a paper on Friday morning discussing the lessons learned in implementing a multi-bus control system in a biotech facility, with a particular emphasis on the Foundation fieldbus elements of the system.
TSU Technology Centre is the newest regional training centre providing certified Foundation fieldbus training courses.
Located in Angola, Indiana, the TSU Technology Centre lab is being equipped with Foundation-compliant host systems and fieldbus instruments provided by Fieldbus Foundation members.
The Foundation is supporting the facility through the creation of a training curriculum for end users, and training of the centre's instructors.
The seminar agenda on Friday, Nov 4, will include an overview of the Fieldbus Foundation global End User Councils (EUCs), presentations concerning Electronic Device Description Language (EDDL) technology and fieldbus economic models, and an update on recent Foundation activities around the world.
Prominent end user companies will also give presentations.
The programme will conclude with a panel discussion involving seminar speakers.
For more information, or to register for the Genzyme seminar, please visit the Fieldbus Foundation website.
• Fieldbus Foundation: contact details and other news
• Email this article to a colleague
• Register for the free Processingtalk email newsletter
• Processingtalk Home Page
Search the Pro-Talk network of sites
